Ricarda Finnern

Mitsubishi Corporation (Germany) — Germany

Medicine · Health Sciences

22h-index2.4kcitations41works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(28), Glycosylation and Glycoproteins Research(10), Transgenic Plants and Applications(10), CRISPR and Genetic Engineering(5), Bacteriophages and microbial interactions(5)

Publications41 total

Online monitoring of the mitochondrial respiration activity and protein formation in the Almost Living Cell-free Expression (ALiCE) system
BMC Biotechnology·2025Open Access
Le click c’est chic: a plug-and-play virus-like particle vaccination platform enabled by non-canonical amino acid incorporation and click chemistry in the tobacco BY-2 cell-free protein synthesis system
2025Open Access
Scaling eukaryotic cell‐free protein synthesis achieved with the versatile and high‐yielding tobacco BY‐2 cell lysate
Biotechnology and Bioengineering·2023· 33 citedOpen Access
Rapid screening and scaled manufacture of immunogenic virus-like particles in a tobacco BY-2 cell-free protein synthesis system
Frontiers in Immunology·2023· 17 citedOpen Access
ALiCE <sup>®</sup> : A versatile, high yielding and scalable eukaryotic cell-free protein synthesis (CFPS) system
2022· 12 citedOpen Access
Plant-Based Cell-Free Transcription and Translation of Recombinant Proteins
Methods in molecular biology·2022· 11 citedOpen Access
Plant molecular farming for the production of valuable proteins – Critical evaluation of achievements and future challenges
Journal of Plant Physiology·2021· 156 citedOpen Access
Pasotuxizumab, a Bite <sup>®</sup> Immune Therapy for Castration-Resistant Prostate Cancer: Phase I, Dose-Escalation Study Findings
Immunotherapy·2020· 133 citedOpen Access
Abstract 2836: Development of a companion diagnostic IHC assay for the biomarker-driven selection of C4.4a positive patients
Cancer Research·2014
Regression of Human Prostate Cancer Xenografts in Mice by AMG 212/BAY2010112, a Novel PSMA/CD3-Bispecific BiTE Antibody Cross-Reactive with Non-Human Primate Antigens
Molecular Cancer Therapeutics·2012· 142 cited
Abstract 4561: Preclinical characterization of MT112/BAY 2010112, a novel PSMA/CD3-bispecific BiTE antibody for the treatment of prostate cancer
Cancer Research·2011· 1 cited
Construction and selection of human SAI/II specific antibody fragments
Figshare·2011Open Access
Binding of human diabodies to SAI/II and coated ELISA plates
Figshare·2011Open Access
Inhibition of chimeric scFv (mGuy13VH/huVL) to SAI/II by the monoclonal Ab Guy13
Figshare·2011Open Access
Specificity of chimeric scFv (mGuy13VH/huVL) ELISA reactivity of overnight induced bacterial culture supernatant containing chimeric scFv (mGuy13VH/huVL) after 3 rounds of selection on SAI/II antigen
Figshare·2011Open Access
T Cell Activation by Antibody-Like Immunoreceptors: The Position of the Binding Epitope within the Target Molecule Determines the Efficiency of Activation of Redirected T Cells
The Journal of Immunology·2007· 103 citedOpen Access
Immunodetection of <i>Venturia inaequalis</i> Ascospores with Phage Antibodies
Journal of Phytopathology·2007· 5 cited
203 POSTER Antitumor efficacy of DX-2400, a potent and selective human antibody MMP-14 inhibitor discovered using phage display technology
European Journal of Cancer Supplements·2006· 1 cited
Recombinant soluble human Fcγ receptor I with picomolar affinity for immunoglobulin G
Biochemical and Biophysical Research Communications·2005· 24 cited
Recombinant anti-EGFR immunotoxin 425(scFv)-ETA' demonstrates anti-tumor activity against disseminated human pancreatic cancer in nude mice
International Journal of Molecular Medicine·2005· 46 cited
page 1 of 3Next →

Frequent Co-authors

Michael Hühn(8), Rainer Fischer(7), Stefan Barth(7), James D. Marks(5), Rainer Fischer(5), Willem H. Ouwehand(5), Holger Spiegel(5), Jacqueline M. Bye(4), Stefan Schillberg(4), C. B. Williams(4), KC Ma Julian(4), Barth Stefan(4), Cindy Wong(3), B.D. Gorick(3), N. C. Hughes‐Jones(3), Peter Kufer(3), M. Sack(3), Mehmet Kemal Tur(3), Igor Fisch(3), Daniela Bruell(3)